Anonymous
Guest
Anonymous
Guest
I guess their in-house robotic research failed. ROFL
Zimmer will purchase one of these soon..watch. Monkey see, monkey do
Tornier
Biomet
Conformis
Carbofix
It's their technology that's valuable. They would still be inexpensive.Conformis blows ass that would be a huge mistake
Mako has lost money for a long time. It's management was imploding from what I know. The business plan isn't sustainable. Zimmer developed a robot for surgery in 2009, only to stop the program when the business case couldn't be made to work. Good decision. Stryker must know something we don't about their intended use for the company or technology.
Stryker routinely knows something we don't. That's why they routinely kick our ass.
I doubt it is Biomet
So after a few years, has Z seen any pressure from Mako in the market?